Tag: NSCLC

Boehringer Ingelheim launches three phase III trials in precision Oncology

Boehringer Ingelheim has initiated three Phase III clinical trials aimed at advancing…

ME Desk

Pfizer Completes Licensing Agreement with 3SBio

Exclusive license to promising investigational cancer immunotherapy complements and strengthens Pfizerโ€™s innovative…

ME Desk